{
    "id": 21239,
    "cites": 13,
    "cited_by": 6,
    "reference": [
        "Association of Public Health Epidemiologists in Ontario (2015). Calculating Potential Years of Life Lost (PYLL), http://www.apheo.ca/index.php?pid=190 Brustugun OT, M\u00c3\u0083\u00c2\u00b8ller B, Helland \u00c3\u0083\u00e2\u0080\u00a6 (2014). Years of life lost as a measure of cancer burden on a national level. British Journal of Cancer 111, 1014\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c1020, http://www.nature.com/bjc/journal/v111/n5/full/bjc2014364a.html Burnet NG, Jefferies SJ, Benson RJ, Hunt DP, Treasure FP (2005). Years of life lost (YLL) from cancer is an important measure of population burden--and should be considered when allocating research funds. British Journal of Cancer 92 (2): 241\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c5, January, http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361853/ Center for Medicare and Medicaid Services (2013), National Health Expenditure Data, http://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-andReports /NationalHealthExpendData/Downloads/tables.pdf.",
        "Dorsey ER, et al (2010). Financial Anatomy of Biomedical Research, 2003 \u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c 2008. Journal of the American Medical Association 303(2), 137\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c143.",
        "Gardner JW, Sanborn JS (1990). Years of potential life lost (YPLL)--what does it measure? Epidemiology 1(4): 322-9, July.",
        "Hirth RA, Chernew ME, Miller E, Fendrick AM, Weissert WG (2000), Willingness to Pay for a Quality-adjusted Life Year: In Search of a Standard, Med Decis Making 20(3): 332-342, Jul-Sep, http://users.phhp.ufl.edu/jharman/healthecon/Hirth%20WTP%20QALY.pdf Honor\u00c3\u0083\u00c2\u00a9 BE, Lleras-Muney A (2006). Bounds in Competing Risks Models and the War on Cancer. Econometrica 74 (6): 1675-1698, November.",
        "Jalan J, Ravallion M (2001) Does Piped Water Reduce Diarrhea for Children in Rural India?, World Bank Development Research Group, Policy Research Working Paper 2664, http://www1.worldbank.org/prem/poverty/ie/dime_papers/332.pdf Law MR (2013). Money Left on the Table: Generic Drug Prices in Canada. Healthcare Policy 8(3): 17\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c25, February, http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3999558/#!po=44.7368/ Lichtenberg FR (2014a). The impact of pharmaceutical innovation on longevity and medical expenditure in France, 2000\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c2009, Economics and Human Biology 13: 107-127, March.",
        "Lichtenberg FR (2014b). Has Medical Innovation Reduced Cancer Mortality? CESifo Economic Studies (2014) 60 (1): 135-177.",
        "National Cancer Institute (2015a). Cancer Screening Overview, http://www.cancer.gov/cancertopics/pdq/screening/overview/patient/page5 National Cancer Institute (2015b). Drug Discovery at the National Cancer Institute, http://www.cancer.gov/cancertopics/factsheet/NCI/drugdiscovery National Cancer Institute (2015c). Person-Years of Life Lost. Cancer Trends Progress Report, 2009/2010 Update, http://progressreport.cancer.gov/doc_detail.asp?pid=1&did=2007&chid=76&coid=730&mid=#e stimate National Cancer Institute (2015d). Off-Label Drug Use in Cancer Treatment, http://www.cancer.gov/about-cancer/treatment/drugs/off-label Nobelprize.org (2015). The Prize in Economics 1987 - Press Release\". http://www.nobelprize.org/nobel_prizes/economic-sciences/laureates/1987/press.html Renard F, Tafforeau J, Deboosere P (2014). Premature mortality in Belgium in 1993-2009: leading causes, regional disparities and 15 years change. Arch Public Health. 2014 Oct 1;72(1):34.",
        "Romer P (1990). Endogenous Technological Change. Journal of Political Economy 98 (5, Part 2), S71-S102.",
        "Sampat BN, Lichtenberg FR (2011). What are the Respective Roles of the Public and Private Sectors in Pharmaceutical Innovation? Health Affairs 30(2), 332-9.",
        "Solow RM (1960). Investment and technological progress, in: Arrow, K., Karlin, S., Suppes, P.",
        "(eds.), Mathematical Methods in Social Sciences 1959, Stanford University Press, 89-104.",
        "Stukel TA, Fisher ES, Wennberg DE, Alter DA, Gottlieb DJ, Vermeulen MJ. (2007) Analysis of Observational Studies in the Presence of Treatment Selection Bias: Effects of Invasive Cardiac Management on AMI Survival Using Propensity Score and Instrumental Variable Methods.",
        "JAMA 297(3):278-285, http://jama.jamanetwork.com/article.aspx?articleid=205172 U.S. Food and Drug Administration (2015), Table of Pharmacogenomic Biomarkers in Drug Labeling, http://www.fda.gov/drugs/scienceresearch/researchareas/pharmacogenetics/ucm083378.htm World Health Organization (2015), ICD-10 Version 2015, Chapter II, Neoplasms, http://apps.who.int/classifications/icd10/browse/2015/en#/II"
    ]
}